1. |
黄清梅, 杜小波. 食管癌相关标志物研究进展. 华西医学, 2017, 32(10): 1620-1623.
|
2. |
Sharifi-Rad J, Ozleyen A, Boyunegmez Tumer T, et al. Natural products and synthetic analogs as a source of antitumor drugs. Biomolecules, 2019, 9(11): 679.
|
3. |
Hu Q, Zhou M, Wei S. Progress on the antimicrobial activity research of clove oil and eugenol in the food antisepsis field. J Food Sci, 2018, 83(6): 1476-1483.
|
4. |
Chua LK, Lim CL, Ling APK, et al. Anticancer potential of syzygium species: a review. Plant Foods Hum Nutr, 2019, 74(1): 18-27.
|
5. |
Vázquez-Fresno R, Rosana ARR, Sajed T, et al. Herbs and spices- biomarkers of intake based on human intervention studies: a systematic review. Genes Nutr, 2019, 14: 18.
|
6. |
Zhu S, Wang J, Xie B, et al. Culture at a higher temperature mildly inhibits cancer cell growth but enhances chemotherapeutic effects by inhibiting cell-cell collaboration. PLoS One, 2015, 10(10): e0137042.
|
7. |
Lin G, Yu B, Liang Z, et al. Silencing of c-jun decreases cell migration, invasion, and EMT in radioresistant human nasopharyngeal carcinoma cell line CNE-2R. Onco Targets Ther, 2018, 11: 3805-3815.
|
8. |
Todorovic V, Prevc A, Zakelj MN, et al. Mechanisms of different response to ionizing irradiation in isogenic head and neck cancer cell lines. Radiat Oncol, 2019, 14(1): 214.
|
9. |
Bezerra DP, Militão GCG, de Morais MC, et al. The dual antioxidant/prooxidant effect of eugenol and its action in cancer development and treatment. Nutrients, 2017, 9(12): 1367.
|
10. |
Arunava D, Harshadha K, Dhinesh Kannan SK, et al. Evaluation of therapeutic potential of eugenol. A natural derivative of syzygium aromaticum on cervical cancer. Asian Pac J Cancer Prev, 2018, 19(7): 1977-1985.
|
11. |
Vijayasteltar L, Nair GG, Maliakel B, et al. Safety assessment of a standardized polyphenolic extract of clove buds: subchronic toxicity and mutagenicity studies. Toxicol Rep, 2016, 3: 439-449.
|
12. |
Dwivedi V, Shrivastava R, Hussain S, et al. Comparative anticancer potential of clove (Syzygium aromaticum)--an Indian spice--against cancer cell lines of various anatomical origin. Asian Pac J Cancer Prev, 2011, 12(8): 1989-1993.
|
13. |
Elsyana V, Bintang M, Priosoeryanto BP. Cytotoxicity and antiproliferative activity assay of clove mistletoe (Dendrophthoe pentandra (L. ) Miq.) leaves extracts. Adv Pharmacol Sci, 2016, 2016: 3242698.
|
14. |
Ryu B, Kim HM, Lee JS, et al. New flavonol glucuronides from the flower buds of Syzygium aromaticum (clove). J Agric Food Chem, 2016, 64(15): 3048-3053.
|
15. |
Li C, Xu H, Chen X, et al. Aqueous extract of clove inhibits tumor growth by inducing autophagy through AMPK/ULK pathway. Phytother Res, 2019, 33(7): 1794-1804.
|
16. |
Liu M, Zhao G, Zhang D, et al. Active fraction of clove induces apoptosis via PI3K/Akt/mTOR-mediated autophagy in human colorectal cancer HCT-116 cells. Int J Oncol, 2018, 53(3): 1363-1373.
|
17. |
Liang WZ, Chou CT, Hsu SS, et al. The involvement of mitochondrial apoptotic pathway in eugenol-induced cell death in human glioblastoma cells. Toxicol Lett, 2015, 232(1): 122-132.
|
18. |
Júnior PL, Câmara DA, Costa AS, et al. Apoptotic effect of eugenol envolves G2/M phase abrogation accompanied by mitochondrial damage and clastogenic effect on cancer cell in vitro. Phytomedicine, 2016, 23(7): 725-735.
|
19. |
Ma M, Ma Y, Zhang GJ, et al. Eugenol alleviated breast precancerous lesions through HER2/PI3K-AKT pathway-induced cell apoptosis and S-phase arrest. Oncotarget, 2017, 8(34): 56296-56310.
|
20. |
Kubatka P, Uramova S, Kello M, et al. Antineoplastic effects of clove buds (Syzygium aromaticum L. ) in the model of breast carcinoma. J Cell Mol Med, 2017, 21(11): 2837-2851.
|
21. |
Liu HZ, Schmitz JC, Wei JT, et al. Clove extract inhibits tumor growth and promotes cell cycle arrest and apoptosis. Oncol Res, 2014, 21(5): 247-259.
|
22. |
Pal D, Sur S, Roy R, et al. Epigallocatechin gallate in combination with eugenol or amarogentin shows synergistic chemotherapeutic potential in cervical cancer cell line. J Cell Physiol, 2019, 234(1): 825-836.
|
23. |
Nam H, Kim MM. Eugenol with antioxidant activity inhibits MMP-9 related to metastasis in human fibrosarcoma cells. Food Chem Toxicol, 2013, 55: 106-112.
|